Guizhou Yibai Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Guizhou Yibai Pharmaceutical has a total shareholder equity of CN¥2.8B and total debt of CN¥840.3M, which brings its debt-to-equity ratio to 30.3%. Its total assets and total liabilities are CN¥4.2B and CN¥1.4B respectively.
Key information
30.3%
Debt to equity ratio
CN¥840.29m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥619.88m |
| Equity | CN¥2.78b |
| Total liabilities | CN¥1.39b |
| Total assets | CN¥4.17b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600594's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥867.2M).
Long Term Liabilities: 600594's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥523.2M).
Debt to Equity History and Analysis
Debt Level: 600594's net debt to equity ratio (7.9%) is considered satisfactory.
Reducing Debt: 600594's debt to equity ratio has reduced from 30.7% to 30.3% over the past 5 years.
Debt Coverage: 600594's debt is well covered by operating cash flow (27.9%).
Interest Coverage: Insufficient data to determine if 600594's interest payments on its debt are well covered by EBIT.